The University of Minnesota has received an $8.6 million contract from the National Institutes of Health (NIH) as part of a federal initiative to accelerate the development of stem-cell therapies for heart, lung and blood diseases and other illnesses. The contract, while small relative to the U's overall body of federally funded research, is almost 8 times larger than a typical NIH grant.